Massachusetts Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.

Press releases published on November 5, 2026

Nov. 5, 2026

FocalTherics™ Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Nyxoah Publie ses Résultats Financiers et Opérationnels du Troisième Trimestre 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

Quantum-Si Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 5, 2026

Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 5, 2026

CAMP4 Reports Third Quarter 2026 Financial Results and Corporate Highlights

Indeterminate GlobeNewswire

Nov. 5, 2026

CVRx Reports Third Quarter 2026 Financial and Operating Results 

Indeterminate GlobeNewswire

Nov. 5, 2026

LB Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Nov. 5, 2026

Rezolute Reports First Quarter Fiscal 2027 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 5, 2026

MediWound Announces Closing of $17.25 Million Bought Deal Offering of Ordinary Shares

Indeterminate GlobeNewswire

Nov. 5, 2026

AVITA Medical Reports Third Quarter Results

Indeterminate GlobeNewswire

Nov. 5, 2026

The Joint Corp. Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

Organogenesis Holdings Inc. Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Solésence To Report Third Quarter 2026 Financial Results and Host a Conference Call on November 12

Indeterminate GlobeNewswire

Nov. 5, 2026

Eton Pharmaceuticals Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

MacroGenics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 5, 2026

Larimar Therapeutics Announces Three Poster Presentations for the Nomlabofusp Program at the Upcoming International Congress for Ataxia Research

Indeterminate GlobeNewswire

Nov. 5, 2026

ICU Medical Announces Third Quarter 2026 Results and Reaffirms Fiscal Year 2026 Guidance, Expecting Results at the High End of Range

Indeterminate GlobeNewswire

Nov. 5, 2026

Sana Biotechnology Reports Third Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Nov. 5, 2026

SkinHealth Systems Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire